Search results
View Cosmo Feilding Mellen’s profile on LinkedIn, a professional community of 1 billion members. Experience: Beckley Psytech · Education: University of Oxford · Location: United Kingdom ·...
- 153
- Beckley Psytech
- 441
- United Kingdom
Cosmo Feilding Mellen CEO Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need.
Cosmo Feilding Mellen CEO Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need.
For our founders, Lady Amanda Feilding and Cosmo Feilding Mellen, psychedelic medicines have been a lifelong and intergenerational vocation. Amanda has dedicated over 50 years to the scientific exploration of psychedelics in the belief that modern science can be used to understand, validate, and optimise the healing potential of psychedelic ...
Cosmo Feilding Mellen is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances. In 2019, he co-founded Beckley Psytech, a private, clinical-stage biotechnology company on a mission to develop novel, rapid-acting, short-duration psychedelic medicines that address the huge unmet need of those ...
Oct 24, 2022 · Cosmo Feilding Mellen, CEO of Beckley Psytech, said: “This is a hugely exciting acquisition for Beckley Psytech, and we are delighted to add Eleusis’ innovative products to our portfolio of...
Cosmo Feilding Mellen. Cosmo is CEO at Beckley Psytech and a drug development entrepreneur dedicated to unlocking the medical potential psychoactive substances, in order to help patients in need.
